Fibrobiologics earnings were -$13.2M for the trailing 12 months ending Jun 30, 2025, with N/A growth year over year. The latest FBLG earnings report on Jun 30, 2025 announced Q2 2025 earnings of -$4.7M, down 6.2% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, FBLG reported annual earnings of -$11.2M, with -41.4% growth. The next FBLG earnings date is Sep 3, 2025.
On FBLG's earnings call on Invalid Date, Fibrobiologics (NASDAQ: FBLG) reported Q2 2025 earnings per share (EPS) of -$0.12, up 500% year over year. Total FBLG earnings for the quarter were -$4.66 million. In the same quarter last year, Fibrobiologics's earnings per share (EPS) was $0.03.
The next FBLG earnings call is Invalid Date. Add FBLG to your watchlist to be reminded of Fibrobiologics's next earnings date.
Is Fibrobiologics profitable or losing money?
As of the last Fibrobiologics earnings report, Fibrobiologics is currently losing money. Fibrobiologics's net profit (also called net income) for the twelve months ending Jun 30, 2025 was -$13.22 million, a 32.09% decrease year over year.
What was FBLG's earnings growth in the past year?
As of Fibrobiologics's earnings date in Invalid Date, Fibrobiologics's earnings has grown year over year. FBLG earnings in the past year totalled -$13.22 million.
What are Fibrobiologics's earnings expectations?
The current EPS estimate for Fibrobiologics's earnings report in Invalid Date is -$0.12.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.